Literature DB >> 14265903

BETA-1-C-GLOBULIN: AN "ACUTE PHASE" SERUM REACTANT OF HUMAN SERUM.

M HORNUNG, R C ARQUEMBOURG.   

Abstract

Entities:  

Keywords:  ADAPTATION, PHYSIOLOGICAL; BETA GLOBULIN; IMMUNOELECTROPHORESIS; SERUM GLOBULINS; STRESS

Mesh:

Substances:

Year:  1965        PMID: 14265903

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  8 in total

1.  Immunoglobulins and complement components in synovial fluid of patients with acute rheumatic fever.

Authors:  M Svartman; E V Potter; T Poon-King; D P Earle
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

2.  Effect of mercaptans and other agents on the human complement component beta-1c-globulin.

Authors:  C B Carpenter; T J Gill
Journal:  Immunology       Date:  1966-04       Impact factor: 7.397

3.  C3 proactivator (C3PA) as an acute phase reactant.

Authors:  M Schutte; R DiCamelli; P Murphy; M Sadove; H Gewurz
Journal:  Clin Exp Immunol       Date:  1974-10       Impact factor: 4.330

4.  Serum complement components in patients with trachoma.

Authors:  D K Sen; G S Sarin; M Hiranandani; U K Baveja
Journal:  Br J Ophthalmol       Date:  1985-09       Impact factor: 4.638

5.  Serum complement component depression during acute adenovirus conjunctivitis.

Authors:  A K Gupta; G S Sarin
Journal:  Br J Ophthalmol       Date:  1984-05       Impact factor: 4.638

6.  The complement profile in relation to the "reactor" state: a study in the immediate post-partum period.

Authors:  L W Mak
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

7.  Differences in the acute phase responses of serum amyloid P-component (SAP) and C3 to injections of casein or bovine serum albumin in amyloid-susceptible and -resistant mouse strains.

Authors:  M L Baltz; K Gomer; A J Davies; D J Evans; G G Klaus; M B Pepys
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

Review 8.  HUS and atypical HUS.

Authors:  T Sakari Jokiranta
Journal:  Blood       Date:  2017-04-17       Impact factor: 25.476

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.